Neurology

Journal

Publication Venue For

  • Bing-Neel syndrome mimicking a meningioma. 2020
  • Cardiovascular risk factors and accelerated cognitive decline in midlife: The CARDIA Study.  95:e839-e846. 2020
  • Minimal manifestation status and prednisone withdrawal in the MGTX trial.  95:e755-e766. 2020
  • Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial.  95:e446-e456. 2020
  • The CREST-2 experience with the evolving challenges of COVID-19: A clinical trial in a pandemic.  95:29-36. 2020
  • Revised Self-Monitoring Scale: A potential endpoint for frontotemporal dementia clinical trials.  94:e2384-e2395. 2020
  • Author response: Dietary patterns during adulthood and cognitive performance in midlife: The CARDIA study.  94:636. 2020
  • Defining research priorities in dystonia.  94:526-537. 2020
  • Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?.  94:481-494. 2020
  • Education Research: Multiple sclerosis and neuroimmunology fellowship training status in the United States.  94:495-500. 2020
  • Child Neurology: Arterial ischemic stroke in a 12-year-old patient with cardiac myxomas.  94:e1103-e1106. 2020
  • APOE ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia..  93:e1807-e1819. 2019
  • Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing.  93:e1452-e1462. 2019
  • Child Neurology: Spastic paraparesis and dystonia with a novel ADCY5 mutation.  93:510-514. 2019
  • Hand stereotypies: Lessons from the Rett Syndrome Natural History Study.  92:E2594-E2603. 2019
  • Reader response: Alien hand syndrome.  92:1070. 2019
  • Inflammatory cytokines and ischemic stroke risk: The REGARDS cohort.  92:E2375-E2384. 2019
  • How should we normalize regional volume abnormalities in childhood neurodegenerative disorders?.  92:779-780. 2019
  • A survey of risk tolerance to multiple sclerosis therapies.  92:E1634-E1642. 2019
  • Dietary patterns during adulthood and cognitive performance in midlife: The CARDIA study.  92:E1589-E1599. 2019
  • A new way to estimate neurologic disease prevalence in the United States: Illustrated with MS.  92:469-480. 2019
  • The prevalence of MS in the United States: A population-based estimate using health claims data.  92:E1029-E1040. 2019
  • Serum magnesium and calcium levels in relation to ischemic stroke: Mendelian randomization study.  92:E944-E950. 2019
  • Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.  92:329-337. 2019
  • Teaching neuroimages: Facial swelling and intracerebral hemorrhage from venous hypertension in a dialysis patient.  92:E521-E522. 2019
  • Word comprehension in temporal cortex and Wernicke area: A PPA perspective.  92:E224-E233. 2019
  • Racial differences in recurrent ischemic stroke risk and recurrent stroke case fatality.  91:E1741-E1750. 2018
  • Sleep duration and risk of incident stroke by age, sex, and race the REGARDS study.  91:E1702-E1709. 2018
  • Outcomes after carotid endarterectomy among elderly dual Medicare-Medicaid-eligible patients.  91:E1553-E1558. 2018
  • Clinical trial design for cutaneous neurofibromas.  91:S31-S37. 2018
  • Cutaneous neurofibromas: Current clinical and pathologic issues.  91:S5-S13. 2018
  • New diagnosis of cancer and the risk of subsequent cerebrovascular events.  90:E2025-E2033. 2018
  • Diet quality is associated with disability and symptom severity in multiple sclerosis.  90:E1-E11. 2018
  • MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study.  90:E264-E272. 2018
  • Cognitive trajectories over 4 years among HIV-infected women with optimal viral suppression.  89:1594-1603. 2017
  • Cognitive trajectories over 4 years among HIV-infected women with optimal viral suppression.  89:1594-1603. 2017
  • Author response: High hypothetical interest in physician-assisted death in multiple sclerosis.  89:1429-1430. 2017
  • Child Neurology: Childhood basilar artery occlusion and stroke.  89:e68-e70. 2017
  • Author response: Practice guideline summary: Use of fMRI in the presurgical evaluation of patients with epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.  89:640-641. 2017
  • Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial.  89:355-362. 2017
  • Body mass index and outcome after revascularization for symptomatic carotid artery stenosis.  88:2052-2060. 2017
  • Child Neurology: LAMA2 muscular dystrophy without contractures.  88:e199-e203. 2017
  • Effect of a long-term intensive lifestyle intervention on prevalence of cognitive impairment.  88:2026-2035. 2017
  • Racial differences in statin adherence following hospital discharge for ischemic stroke.  88:1839-1848. 2017
  • Evidence for a causal relationship between low Vitamin D, high BMI, and pediatric-onset MS.  88:1623-1629. 2017
  • High hypothetical interest in physician-assisted death in multiple sclerosis.  88:1528-1534. 2017
  • Letter re: Mechanisms of memory impairment in epilepsy depend on age at disease onset.  88:1482-1483. 2017
  • Natalizumab-associated PML: Challenges with incidence, resulting risk, and risk stratification.  88:1197-1205. 2017
  • Long-term functional outcome in patients with acquired infections after acute spinal cord injury.  88:892-900. 2017
  • Practice guideline summary: Use of fMRI in the presurgical evaluation of patients with epilepsy.  88:395-402. 2017
  • A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.  88:152-159. 2017
  • Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1.  87:2575-2584. 2016
  • Effect of aphasia on acute stroke outcomes.  87:2348-2354. 2016
  • Neighborhood socioeconomic index and stroke incidence in a national cohort of blacks and whites.  87:2340-2347. 2016
  • Pearls and Oy-sters: The chapeau de gendarme sign and other localizing gems in frontal lobe epilepsy.  87:e103-e105. 2016
  • Twelve-month recovery of medical decision-making capacity following traumatic brain injury.  87:1052-1059. 2016
  • Pediatric multiple sclerosis Clinical features and outcome.  87:S74-S81. 2016
  • Symptom profiles of autism spectrum disorder in tuberous sclerosis complex.  87:766-772. 2016
  • Current status and recommendations for biomarkers and biobanking in neurofibromatosis.  87:S40-S48. 2016
  • Health insurance affects the use of disease-modifying therapy in multiple sclerosis.  87:365-374. 2016
  • Hostile attitudes and effortful coping in young adulthood predict cognition 25 years later.  86:1227-1234. 2016
  • Clinical Reasoning: Seizures from the neglected lobe.  86:e97-e100. 2016
  • Differences in the role of black race and stroke risk factors for first vs recurrent stroke.  86:637-642. 2016
  • Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report.  86:245-252. 2016
  • Lower physical activity is associated with higher disease burden in pediatric multiple sclerosis.  85:1663-1669. 2015
  • Marijuana Usage and Disability in MS in the NARCOMS Registry.  April 06, 2015; 84 (14 Supplement):P1.140-P1.140. 2015
  • Differences in Alzheimer disease clinical trial outcomes based on age of the participants.  84:1121-1127. 2015
  • Quality improvement in neurology: primary headache quality measures..  84:200-203. 2015
  • Author response.  85:742-743. 2015
  • DNA methylation slows effects of C9orf72 mutations.  84:1616-1617. 2015
  • Emerging Subspecialties in Neurology: Neurorehabilitation.  85:e50-e52. 2015
  • Ictal adipokines are associated with pain severity and treatment response in episodic migraine.  84:1409-1418. 2015
  • Long-term impact of stroke on family caregiver well-being: A population-based case-control study.  84:1323-1329. 2015
  • New-onset refractory status epilepticus.  85:1604-1613. 2015
  • Placebo effect of medication cost in Parkinson disease: A randomized double-blind study.  84:794-802. 2015
  • Anatomical heterogeneity of Alzheimer disease Based on cortical thickness on MRIs.  83:1936-1944. 2014
  • Clinical response to Bevacizumab in schwannomatosis.  83:1986-1987. 2014
  • Protective environmental factors for neuromyelitis optica.  83:1923-1929. 2014
  • ABO blood type, factor VIII, and incident cognitive impairment in the REGARDS cohort.  83:1271-1276. 2014
  • JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene..  83:727-732. 2014
  • Assessing decisional capacity in patients with brain tumors.  83:482-483. 2014
  • Defining the clinical course of multiple sclerosis: The 2013 revisions.  83:278-286. 2014
  • Spectrogram screening of adult EEGs is sensitive and efficient.  83:56-64. 2014
  • Paroxysmal hypnogenic dyskinesia.  82:1935. 2014
  • Feasibility of Huntington disease trials in the disease prodrome.  82:824-825. 2014
  • Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON) trial.  82:744-751. 2014
  • Clinically meaningful performance benchmarks in MS:Timed 25-Foot Walk and the real world.  81:1856-1863. 2013
  • Decisional capacity in cognitively impaired patients with Parkinson disease.  81:780-781. 2013
  • Mortality in patients with multiple sclerosis.  81:184-192. 2013
  • Report of stroke-like symptoms predicts incident cognitive impairment in a stroke-free cohort.  81:113-118. 2013
  • Management of carotid stenosis in women consensus document.  80:2258-2268. 2013
  • Cerebral hemodynamics and cognitive decline: Swimming against the current.  80:2086-2087. 2013
  • Pearls and Oy-sters: Acute ischemic stroke caused by atypical thrombotic thrombocytopenic purpura.  80. 2013
  • Clinicopathologic variability of the GRN A9D mutation, including amyotrophic lateral sclerosis.  80:1771-1777. 2013
  • Adherence to a Mediterranean diet and risk of incident cognitive impairment.  80:1684-1692. 2013
  • Effect of duration and age at exposure to the Stroke Belt on incident stroke in adulthood.  80:1655-1661. 2013
  • Disability in multiple sclerosis: A reference for patients and clinicians.  80:1018-1024. 2013
  • Functional impairment in progressive supranuclear palsy.  80:380-384. 2013
  • Recommendations for imaging tumor response in neurofibromatosis clinical trials..  81. 2013
  • Assessment of cortical and striatal involvement in 523 Huntington disease brains.  79:1708-1715. 2012
  • Growth failure and outcome in Rett syndrome: Specific growth references.  79:1653-1661. 2012
  • Racial differences in albuminuria, kidney function, and risk of stroke.  79:1686-1692. 2012
  • What is it about neighborhood characteristics that influence survival after a stroke or TIA?.  79:1190-1191. 2012
  • Prevalence and significance of stroke symptoms among patients receiving maintenance dialysis.  79:981-987. 2012
  • MRI-leukoaraiosis thresholds and the phenotypic expression of dementia.  79:734-740. 2012
  • Novel late-onset Alzheimer disease loci variants associate with brain gene expression..  79:221-228. 2012
  • Treatment consent capacity in patients with traumatic brain injury across a range of injury severity.  78:1472-1478. 2012
  • Cognitive performance of GBA mutation carriers with early-onset PD The CORE-PD study.  78:1434-1440. 2012
  • Survival in MS A randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial.  78:1315-1322. 2012
  • CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.  78:690-695. 2012
  • Incidence and prevalence of epilepsy among older US Medicare beneficiaries.  78:448-453. 2012
  • Carotid stenosis: To revascularize, or not to revascularize: That is the question.  78:294. 2012
  • Carotid stenosis: to revascularize, or not to revascularize: that is the question..  78:294. 2012
  • Cerebral hemodynamics and cognitive impairment: Baseline data from the RECON trial.  78:250-255. 2012
  • Normal pressure hydrocephalus: Measure twice, shunt once.  78:225-226. 2012
  • Evaluation of safety monitoring guidelines based on MRI lesion activity in multiple sclerosis.  77:2089-2096. 2011
  • To the editor.  77:1998-1999. 2011
  • Reply from the authors.  77. 2011
  • Clinical severity and quality of life in children and adolescents with Rett syndrome.  77:1812-1818. 2011
  • Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease).  77:1801-1807. 2011
  • Vascular risk factors and cognitive impairment in a stroke-free cohort.  77:1729-1736. 2011
  • To the editor.  77. 2011
  • Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS.  77:138-144. 2011
  • Common viruses associated with lower pediatric multiple sclerosis risk.  76:1989-1995. 2011
  • Behavioral therapy to treat urinary incontinence in Parkinson disease.  76:1631-1634. 2011
  • Interferon β-1b and glatiramer acetate effects on permanent black hole evolution.  76:1222-1228. 2011
  • NMO Spectrum Disorder in Children and Adolescents.  76:A395-A396. 2011
  • Pituitary Adenoma Complicated By Multifocal Fibrosclerosis Involving Sella and Retroperitoneum.  76:A250-A251. 2011
  • Recurrent Demyelinating Events Following Pediatric Optic Neuritis (pON).  76:A394-A394. 2011
  • Racial and geographic differences in fish consumption: The regards study.  76:154-158. 2011
  • Neurocognitive sequelae in African American and Caucasian children with multiple sclerosis.  75:2097-2102. 2010
  • A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2.  75:1189-1194. 2010
  • A case of neurosarcoidosis successfully treated with rituximab.  75:568-570. 2010
  • Reply from the authors.  74:1554-1555. 2010
  • Epilepsy and the natural history of Rett syndrome.  74:909-912. 2010
  • 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men.  74:33-41. 2010
  • Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis.  74:1041-1047. 2010
  • Younger children with MS have a distinct CSF inflammatory profile at disease onset.  74:399-405. 2010
  • Association of higher diastolic blood pressure levels with cognitive impairment.  73:589-595. 2009
  • Subthalamic nucleus and its connections: Anatomic substrate for the network effects of deep brain stimulation.  72:1110. 2009
  • Depression in Pediatric MS Patients Correlates with Increased Disease Severity and Selective Neuropsychological Deficits.  72:A371-A372. 2009
  • Hepatitis vaccines and pediatric multiple sclerosis: Does timing or type matter?.  72:870-871. 2009
  • Personality and lifestyle in relation to dementia incidence.  72:253-259. 2009
  • Comorbidity delays diagnosis and increases disability at diagnosis in MS.  72:117-124. 2009
  • A cross-sectional study of bone health in multiple sclerosis.  73:1394-1398. 2009
  • Declining financial capacity in mild cognitive impairment: A 1-year longitudinal study.  73:928-934. 2009
  • Declining financial capacity in patients with MCI: A one-year longitudinal study.  73:928-934. 2009
  • Editorial: Relapses in multiple sclerosis: Important or not?.  73:1612-1613. 2009
  • Medical decision-making capacity in patients with malignant glioma.  73:2086-2092. 2009
  • Invited Article: The US health care system: Part 1: Our current system.  71:1907-1913. 2008
  • Invited article: The US health care system: Part 2: Proposals for improvement and comparison to other systems.  71:1914-1920. 2008
  • Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis: Reply.  71:1747-1748. 2008
  • Medical decision-making capacity in mild cognitive impairment: A 3-year longitudinal study.  71:1474-1480. 2008
  • A novel PRNP-P105S mutation associated with atypical prion disease and a rare PrPSc conformation..  71:1431-1438. 2008
  • CNS aquaporin-4 autoimmunity in children.  71:93-100. 2008
  • Haplotypes and gene expression implicate the MAPT region for Parkinson disease: The GenePD Study.  71:28-34. 2008
  • A test of the mechanisms of sensory extinction to simultaneous stimulation.  70:1644-1645. 2008
  • Ethics of placebo-controlled clinical trials in multiple sclerosis: A reassessment.  70:1134-1140. 2008
  • Investigating genotype-phenotype relationships in Rett syndrome using an international data set.  70:868-875. 2008
  • Responsiveness and predictive values in PPMS: An uncertain message.  70:1061-1062. 2008
  • Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome.  70:1313-1321. 2008
  • Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: Redefining DYT14 as DYT5.  70:1377-1383. 2008
  • Medical decision-making capacity in patients with mild cognitive impairment.  69:1528-1535. 2007
  • Attentional distractibility by optokinetic stimulation in Alzheimer disease.  69:1105-1112. 2007
  • Dissociation of neglect subtypes with transcranial magnetic stimulation.  69:1122-1127. 2007
  • Erratum: Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease (Neurology (2007) 68, (272-276)).  69:617. 2007
  • MR tractography depicting damage to the arcuate fasciculus in a patient with conduction aphasia [6].  69:321. 2007
  • Disparities in the management of multiple sclerosis-related bladder symptoms.  68:1971-1978. 2007
  • Is decreased dexterity in Parkinson disease due to apraxia? [1].  68:2044. 2007
  • Frontal mysteries revealed.  68:1450-1453. 2007
  • Migraine and retinal microvascular abnormalities: The Atherosclerosis Risk in Communities Study.  68:1694-1700. 2007
  • Predictors of diagnosis in Huntington disease.  68:1710-1717. 2007
  • Nothing out of sequence? Think deletion!.  68:975-976. 2007
  • NF1 plexiform neurofibroma growth rate by volumetric MRI: Relationship to age and body weight.  68:643-647. 2007
  • A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease.  68:20-28. 2007
  • Acute disseminated encephalomyelitis.  68. 2007
  • Clinical features of children and adolescents with multiple sclerosis.  68. 2007
  • Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy.  68:364-368. 2007
  • Limb-kinetic apraxia in Parkinson disease.  68:150-151. 2007
  • MRI features of pediatric multiple sclerosis.  68. 2007
  • Optical coherence tomography and disease subtype in multiple sclerosis.  69:2085-2092. 2007
  • Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease.  68:272-276. 2007
  • Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease (Neurolgy (2007) 68, (272-276)).  69:2187. 2007
  • Relation of vision to global and regional brain MRI in multiple sclerosis.  69:2128-2135. 2007
  • Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.  69:1603-1609. 2007
  • Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: The GenePD study.  67:2206-2210. 2006
  • Improving caregiver well-being delays nursing home placement of patients with Alzheimer disease.  67:1592-1599. 2006
  • The Motor Activity Log-28: Assessing daily use of the hemiparetic arm after stroke.  67:1189-1194. 2006
  • What's inside the art? The influence of frontotemporal dementia in art production.  67:1285-1287. 2006
  • Early progressive encephalopathy in boys and MECP2 mutations.  67:164-166. 2006
  • Elevated troponin levels are associated with higher mortality following intracerebral hemorrhage.  66:1330-1334. 2006
  • Perception of motor strength and stimulus magnitude are correlated in stroke patients.  66:1444-1446. 2006
  • Does multiple sclerosis-associated disability differ between races?.  66:1235-1240. 2006
  • Futility studies: Spending a little to save a lot.  66:626-627. 2006
  • Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis [3].  66:954. 2006
  • A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease.  66:664-671. 2006
  • Deafferentation- Disconnection neglect induced by posterior cerebral artery infarction.  66:56-61. 2006
  • Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders.  65:1941-1949. 2005
  • BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study.  65:1823-1825. 2005
  • Occupation and parkinsonism in three movement disorders clinics.  65:1430-1435. 2005
  • Changes in the ascertainment of multiple sclerosis.  65:1066-1070. 2005
  • MRI as a marker for disease heterogeneity in multiple sclerosis.  65:1071-1076. 2005
  • Frontotemporal dementia progresses to death faster than Alzheimer disease.  65:719-725. 2005
  • Does gender parity exist in Fabry disease?.  65:508-509. 2005
  • Blood harmane concentrations and dietary protein consumption in essential tremor.  65:391-396. 2005
  • Efficacy of rapid IV administration of valproic acid for status epilepticus [3] (multiple letters).  65:500-501. 2005
  • Medical decision-making in neurodegenerative disease: Mild AD and PD with cognitive impairment.  65:483-485. 2005
  • Subcortical vascular dementia: Integrating neuropsychological and neuroradiologic data.  65:376-382. 2005
  • A clinical rating scale for Batten disease: Reliable and relevant for clinical trials.  65:275-279. 2005
  • Spinal fluid 5-methyltetrahydrofolate levels are normal in Rett syndrome.  64:2151-2152. 2005
  • Donepezil improved memory in multiple sclerosis in a randomized clinical trial [4] (multiple letters).  64:1823. 2005
  • Headache, cerebrovascular symptoms, and stroke: The atherosclerosis risk in communities study.  64:1573-1577. 2005
  • Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.  64:992-995. 2005
  • Unilateral cerebral peduncular atrophy progresses for decades after stroke.  64:A110-A110. 2005
  • Unawareness of cognitive deficit (cognitive anosognosia) in probable AD and control subjects.  64:693-699. 2005
  • Efficacy of rapid IV administration of valproic acid for status epilepticus.  64:353-355. 2005
  • Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American Academy of Neurology, the American Association of Neurological Surgeons, the American Society of Interventional and Therapeutic Neuroradiology, the American Society of Neuroradiology, the Congress of Neurological Surgeons, the AANS/CNS Cerebrovascular Section, and the Society of Interventional Radiology..  64:190-198. 2005
  • Training, competency, and credentialing standards for diagnostic cervicocerebral angiograpny, carotid stenting, and cerebrovascular intervention: A Joint Statement from the American Academy of Neurology, the American Association of Neurological Surgeons, the American Society of Interventional and Therapeutic Neuroradiology, and the Society of Interventional Radiology.  64:190-198. 2005
  • Intracranial arterial dolichoectasia is associated with enlarged descending thoracic aorta [1] (multiple letters).  65:1681-1682. 2005
  • Multifocal motor sensory demyelinating neuropathy: Inflammatory demyelinating polyradiculoneuropathy.  65:1639-1642. 2005
  • Pacemaker-induced tachycardia caused by inappropriate response to parkinsonian tremor.  65:1676-1677. 2005
  • Migraine and other headaches: Associations with Rose angina and coronary heart disease.  63:2233-2239. 2004
  • Spatial cognition.  63:1994-1996. 2004
  • Cortical reorganization in malformations of cortical development: A magnetoencephalographic study.  63:1818-1824. 2004
  • Aberrant auditory processing and atypical planum temporale in developmental stuttering.  63:1640-1646. 2004
  • The evolving role of monoamine oxidase inhibitors in the treatment of Parkinson's disease.  63. 2004
  • Disorganized search on cancellation is not a consequence of neglect.  63:78-84. 2004
  • Emotional prosody in primary progressive aphasia.  63:192-193. 2004
  • On-line anosognosia: Unawareness for chorea in real time but not on videotape delay.  63:159-160. 2004
  • Attentional bias induced by viewing actual or illusory movements.  62:1333-1337. 2004
  • Eclampsia, hippocampal sclerosis, and temporal lobe epilepsy: Accident or association?.  62:1352-1356. 2004
  • Ophthalmologic features of Parkinson's disease.  62:177-180. 2004
  • Frequency of epilepsy in patients with psychogenic seizures monitored by video-EEG.  61:1791-1792. 2003
  • A haplotype at the PARK3 locus influences onset age for Parkinson's disease: The GenePD study.  61:1557-1561. 2003
  • Adenosine A2A receptor modulation of motor systems for symptomatic therapy in Parkinson's disease..  61:S30-S31. 2003
  • Effect of relapses on development of residual deficit in multiple sclerosis.  61:1528-1532. 2003
  • II: A2A receptor modulation for symptomatic therapy in Parkinson's disease: Adenosine A2A receptor modulation of motor systems in PD.  61. 2003
  • Subacute inflammatory demyelinating polyneuropathy.  61:1507-1512. 2003
  • Atypical cerebral laterality in adults with persistent developmental stuttering.  61:1378-1385. 2003
  • Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite.  61:1367-1373. 2003
  • Teddy bears: An observational finding in patients with non-epileptic events.  61:714-715. 2003
  • Ipsilateral neglect versus hemianopic compensation.  61:120-123. 2003
  • Neurotoxicity following addition of intravenous valproate to lamotrigine therapy.  60:1991-1992. 2003
  • Prism adaptation treatment of neglect: Conflicting results?.  60:1734-1735. 2003
  • A note of caution on correlation between sibling pairs [6] (multiple letters).  60:1561. 2003
  • Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.  60:1189-1191. 2003
  • Progressive affective aprosodia and prosoplegia.  60:1192-1194. 2003
  • Predictors of nursing home placement in Huntington disease.  60:998-1001. 2003
  • Ecological implications of ideomotor apraxia: Evidence from physical activities of daily living.  60:487-490. 2003
  • Impaired financial abilities in mild cognitive impairment: A direct assessment approach.  60:449-457. 2003
  • Tic reduction in Tourette Syndrome: improvement with pergolide in a randomized controlled trial in children.  60:606-611. 2003
  • Is the middle between both halves? Midpoint location and segment size estimation in neglect.  59:1580-1584. 2002
  • Eight-year follow-up study of brain atrophy in patients with MS.  59:1412-1420. 2002
  • Weight loss in early stage of Huntington's disease.  59:1325-1330. 2002
  • Benefit of interferon β-1a on MSFC progression in secondary progressive MS.  59:679-687. 2002
  • Clinical and genetic heterogeneity in benign hereditary chorea.  59:579-584. 2002
  • Dopamine transmission in DYT1 dystonia: A biochemical and autoradiographical study.  59:445-448. 2002
  • Language lateralization in left-handed and ambidextrous people: fMRI data.  59:238-244. 2002
  • Influence of final search direction on tactile line bisection in normal subjects.  58:1833-1838. 2002
  • The contribution of an avoidance response to contralateral neglect.  58:1692-1694. 2002
  • Plexiform neurofibromas in NF1: Toward biologic-based therapy.  58:1461-1470. 2002
  • Porphyria presenting with bilateral radial motor neuropathy: Evidence of a novel gene mutation.  58:1118-1121. 2002
  • HLA-A2 homozygosity but not heterozygosity is associated with Alzheimer disease.  58:973-975. 2002
  • Depression associated with Parkinson's disease: Clinical features and treatment.  58. 2002
  • Treatment of ADHD in children with tics: A randomized controlled trial.  58:527-536. 2002
  • Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults.  58:368-372. 2002
  • Speaking while gesturing: The relationship between speech and limb praxis.  58:499-500. 2002
  • Epidemiologic study of 203 sibling pairs with Parkinson's disease: The GenePD study.  58:79-84. 2002
  • Genome-wide scan for Parkinson's disease: The GenePD study.  57:1124-1126. 2001
  • Bilateral hippocampal atrophy: Consequences to verbal memory following temporal lobectomy.  57:597-604. 2001
  • Chromosome 22q and the mind-brain interface: Bedside to bench to bedside.  57:377-378. 2001
  • Anomalous anatomy of speech-language areas in adults with persistent developmental stuttering.  57:207-215. 2001
  • Extinction, working memory, and line bisection in spatial neglect.  57:147-149. 2001
  • Large-fiber neuropathy in distal sensory neuropathy with normal routine nerve conduction.  56:1570-1572. 2001
  • Parkinson's disease, CYP2D6 polymorphism, and age.  56:1363-1370. 2001
  • Use of the multiple sclerosis functional composite to predict disability in relapsing MS.  56:1324-1330. 2001
  • Left vagus nerve stimulation suppresses experimentally induced pain [3] (multiple letters).  56:985-986. 2001
  • Seeing trees but not the forest: Limited perception of large configurations in PD.  56:724-729. 2001
  • Chronic thalamic stimulation for treatment of dystonic paroxysmal nonkinesigenic dyskinesia.  56:268-270. 2001
  • Emotional conversations in Parkinson's disease.  56:159-165. 2001
  • Postictal stability of proton magnetic resonance spectroscopy imaging (1H-MRSI) ratios in temporal lobe epilepsy.  56:251-253. 2001
  • Cardiovascular risk factors and cognitive decline in middle-aged adults.  56:42-48. 2001
  • Competency to consent to medical treatment in cognitively impaired patients with Parkinson's disease.  56:17-24. 2001
  • Sensory Guillain-Barré syndrome.  56:82-86. 2001
  • An algorithm (decision tree) for the management of Parkinson's disease (2001): Treatment guidelines.  56. 2001
  • Four-year incidence of psychogenic nonepileptic seizures in adults in Hamilton County, OH.  55:1561-1563. 2000
  • Pelizaeus-Merzbacher disease: Splice sites are nice sites for disease expression.  55:1072-1073. 2000
  • The experience of Wernicke's aphasia.  55:1222-1224. 2000
  • Low mini-mental status predicts mortality in asymptomatic carotid arterial stenosis.  55:30-34. 2000
  • Low mini-mental status predicts mortality in asymptomatic carotid arterial stenosis. Asymptomatic Carotid Atherosclerosis Study investigators..  55:30-34. 2000
  • Visual attention impairments in Alzheimer's disease.  54:1954-1959. 2000
  • Pure topographic disorientation: A distinctive syndrome with varied localization.  54:1864-1866. 2000
  • Testing memory for self-generated items in dementia: Method makes a difference.  54:1258-1264. 2000
  • Enlarged parietal foramina: Association with cerebral venous and cortical anomalies.  54:1175-1178. 2000
  • Intrarater and interrater reliability of the MS functional composite outcome measure.  54:802-806. 2000
  • A randomized trial of 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome.  54:603-607. 2000
  • Arm levitation in progressive supranuclear palsy..  54:774. 2000
  • Rate of functional decline in Huntington's disease.  54:452-458. 2000
  • Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults [2] (multiple letters).  54:270-272. 2000
  • Hemispheric asymmetries of limb-kinetic apraxia: A loss of deftness.  55:523-526. 2000
  • Proprioception more impaired distally than proximally in subjects with hemispheric dysfunction.  55:596-597. 2000
  • Pure topographic disorientation: A distinctive syndrome with varied localization.  54:575-578. 2000
  • Cerebral lateralization: Relationship of language and ideomotor praxis.  53:2028-2031. 1999
  • Cognitive correlates of 1H MRSI-detected hippocampal abnormalities in temporal lobe epilepsy.  53:2052-2058. 1999
  • Error behaviors associated with loss of competency in Alzheimer's disease.  53:1983-1992. 1999
  • Ipsilesional intentional neglect and the effect of cueing.  53:2017-2022. 1999
  • Visual dysfunction in patients receiving vigabatrin: Clinical and electrophysiologic findings.  53:2082-2087. 1999
  • Eliminating institutional child abuse: A road too well traveled.  53:1617-1621. 1999
  • Juvenile Parkinson's disease with REM sleep behavior disorder, sleepiness, and daytime REM onset.  53:1868-1870. 1999
  • Subjective versus objective memory change after temporal lobe epilepsy surgery.  53:1511-1517. 1999
  • Evidence for the GluR6 gene associated with younger onset age of Huntington's disease.  53:1330-1332. 1999
  • Clinical and laboratory features of primary progressive and secondary progressive MS.  53:765-771. 1999
  • Cognitive consequences of coexisting temporal lobe developmental malformations and hippocampal sclerosis.  53:709-715. 1999
  • Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy.  53:687-694. 1999
  • Predictive value of 1H MRSI for outcome in temporal lobectomy.  53:694-698. 1999
  • Quantitative MRI in temporal lobe epilepsy: Evidence for fornix atrophy.  53:496-501. 1999
  • Facilitory paratonia and frontal lobe functioning [3] (multiple letters).  53:241. 1999
  • Motor perseverative behavior on a line cancellation task.  52:1569-1576. 1999
  • Neglect after right hemisphere stroke [7] (multiple letters).  52:1721-1722. 1999
  • Infarction in the territory of the anterior cerebral artery [4] (multiple letters).  52:1519. 1999
  • Facilitory paratonia and frontal lobe functioning [5] (multiple letters).  52:1109. 1999
  • Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.  52:321-327. 1999
  • Neglect after right hemisphere stroke.  52:1722. 1999
  • Temporal lobe developmental malformations and hippocampal sclerosis epilepsy surgical outcome.  52:479-484. 1999
  • Temporal lobe developmental malformations and hippocampal sclerosis: Epilepsy surgery outcome.  53:694-698. 1999
  • Lesion laterality, neglect, and anosognosia..  51:920-921. 1998
  • Frontal lobe neglect in man. 1972..  50. 1998
  • 1H NMR spectroscopy studies of Huntington's disease. Correlations with CAG repeat numbers.  50:1357-1365. 1998
  • A cross-reactive anti-myelin basic protein idiotope in cerebrospinal fluid cells in multiple sclerosis.  50:411-417. 1998
  • Age-related changes in the level of urinary myelin basic protein-like material during childhood.  51:1339-1341. 1998
  • Central poststroke pain and Wallenberg's lateral medullary infarction.  50:1521. 1998
  • Central poststroke pain associated with lateral medullary infarction.  50:837. 1998
  • Could pure alexia be due to a disconnection syndrome?.  50:835. 1998
  • Dissociation of gesture and object recognition.  50:1186-1188. 1998
  • Facilitory paratonia and frontal lobe functioning.  51:968-971. 1998
  • Ipsilateral neglect during intracarotid amobarbital test.  51:276-279. 1998
  • Lesion laterality, neglect, and anosognosia [4] (multiple letters).  51:920-921. 1998
  • Neglect after right hemisphere stroke: A smaller floodlight for distributed attention.  51:972-978. 1998
  • Progressive ventral posterior cortical degeneration presenting as alexia for music and words.  50:657-659. 1998
  • Topiramate increases brain GABA in healthy adults.  51:627-629. 1998
  • Topiramate increases cerebral GABA in healthy humans.  51:627-629. 1998
  • Touching and timing consciousness.  51:666-668. 1998
  • Clearing up misunderstandings about clinical trial methodology: a reply to Barnett et al.'s commentary on the ACAS Trial. ACAS Executive Committee, ACAS Data and Safety Monitoring Committee..  48:1743-1745. 1997
  • Differential diagnosis of Alzheimer's disease.  48. 1997
  • Anosognosia and confabulation during the Wada test.  49:1316-1322. 1997
  • Anterior translocation of language in patients with left cerebral arteriovenous malformation.  49:802-808. 1997
  • Central poststroke pain and Wallenberg's lateral medullary infarction: Frequency, character, and determinants in 63 patients.  49:120-125. 1997
  • Chromosome 17 and hereditary dementia: Linkage studies in three non- Alzheimer families and kindreds with late-onset FAD.  48:949-954. 1997
  • Clearing up misunderstandings about clinical trial methodology: A reply to Barnett et al.'s commentary on the ACAS trial [2] (multiple letters).  48:1743-1748. 1997
  • Conceptual apraxia from lateralized lesions.  49:457-464. 1997
  • Congenital porencephaly and hippocampal sclerosis: Clinical features and epileptic spectrum.  49:1382-1388. 1997
  • Corticobasal degeneration: Neuropathologic and clinical heterogeneity.  48:959-969. 1997
  • Epilepsy surgery outcome: Comprehensive assessment in children.  48:1368-1374. 1997
  • Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease.  49:512-518. 1997
  • Hemianopic anosognosia.  49:88-97. 1997
  • Krabbe continuum or clinical conundrum?.  49:1203-1204. 1997
  • Oral phenylalanine loading in dopa-responsive dystonia: A possible diagnostic test.  48:1290-1297. 1997
  • Search patterns using the line bisection test for neglect.  49:936-940. 1997
  • Selective deficit of praxis imagery in ideomotor apraxia.  49:474-480. 1997
  • Spatial bias: Attentional and intentional influence in normal subjects.  48:234-242. 1997
  • The role of dopamine agonists in early Parkinson's disease.  49. 1997
  • Validation of the ACAS TIA/stroke algorithm.  48:346-351. 1997
  • Ventral tegmental area injury and frontal lobe disorder.  46:842-843. 1996
  • Apolipoprotein E ∈4 association with dementia in a population-based study: The Framingham Study.  46:673-677. 1996
  • Increased risk of familial late-onset Alzheimer's disease in women.  46:126-129. 1996
  • Leukoencephalopathy associated with cobalamin deficiency.  46:832-834. 1996
  • Motor neglect: What do we mean?.  46:1492-1493. 1996
  • Mutation of the prion protein gene at codon 208 in familial Creutzfeldt- Jakob disease.  47:1305-1312. 1996
  • Positive spontaneous visual phenomena limited to the hemianopic field in lesions of central visual pathways.  47:408-417. 1996
  • Reply from the Author: Gender and AD.  47:1358. 1996
  • Spontaneous grammatical corrections in an anomic aphasic.  47:845-846. 1996
  • Toward a neurologic model of competency: Cognitive predictors of capacity to consent in Alzheimer's disease using three different legal standards.  46:666-672. 1996
  • Sorivudine: a promising drug for the treatment of varicella-zoster virus infection..  45:S73-S75. 1995
  • Anosognosia during intracarotid barbiturate anesthesia: Unawareness or amnesia for weakness.  45:241-243. 1995
  • Anosognosia for hemiplegia: Test of the personal neglect hypothesis.  45:2195-2199. 1995
  • Apraxia during wada testing.  45:1379-1383. 1995
  • Attention and anosognosia: The case of a jargonaphasic patient with unawareness of language deficit.  45:376-378. 1995
  • Circulating adhesion molecules and inflammatory mediators in demyelination: A review.  45:S22-S32. 1995
  • Cytokine localization in multiple sclerosis lesions: Correlation with adhesion molecule expression and reactive nitrogen species.  45:S16-S21. 1995
  • Dissociation of anosognosia for hemiplegia and aphasia during left-hemisphere anesthesia.  45:65-67. 1995
  • Emotional facial imagery, perception, and expression in parkinson's disease.  45:1696-1702. 1995
  • Frontal lobe neglect in monkeys.  45:1205-1210. 1995
  • Genetic anticipation in parkinson's disease.  45:135-138. 1995
  • Impaired perception of facial identity and facial affect in huntington's disease.  45:1217-1218. 1995
  • Inhibitory cytokines and cytokine inhibitors.  45:S39-S43. 1995
  • No evidence for association of familial parkinson's disease with cag repeat expansion.  45:1760-1763. 1995
  • Reading comprehension in a transcortical motor aphasic.  45:1418. 1995
  • Sorivudine: A promising drug for the treatment of varicella-zoster virus infection.  45:S73-S75. 1995
  • VISUAL PHENOMENA LIMITED TO THE HEMIANOPIC FIELD IN LESIONS OF THE CENTRAL VISUAL PATHWAYS.  44:A266-A266. 1994
  • A clinical genetic study of parkinson’s disease: Evidence for dominant transmission.  44:499-506. 1994
  • Anosognosia for hemiplegia: An electrophysiologic investigation of the feed–forward hypothesis.  44:1804-1808. 1994
  • Motor neglect associated with a discrete parietal lesion.  44:1164-1166. 1994
  • Progressive supranuclear palsy: Neuropathologic and clinical heterogeneity.  44:1015-1024. 1994
  • Chiari headaches.  43:1272. 1993
  • Disruption of automatic speech following a right basal ganglia lesion.  43:1768-1774. 1993
  • Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of huntington's disease: A quantitative golgi study.  43:2088-2096. 1993
  • Extrapersonal neglect [2].  43:1859-1860. 1993
  • Nonoptic aphasia: Aphasia with preserved confrontation naming in alzheimer's disease.  43:1900-1907. 1993
  • Left hemiparalexia..  42:562-569. 1992
  • A syndrome of autosomal dominant alternating hemiplegia: Clinical presentation mimicking intractable epilepsy; chromosomal studies; and physiologic investigations.  42:2251-2257. 1992
  • Anosognosia during wada testing.  42:925-927. 1992
  • Kynurenine pathway abnormalities in Parkinson's disease.  42:1702-1706. 1992
  • Left hemiparalexia.  42:562-569. 1992
  • Subacute necrotizing encephalopathy: Oxidative phosphorylation defects and the ATPase 6 point mutation.  42:2168-2174. 1992
  • Clozapine is beneficial for psychosis in parkinson's disease.  41:1699-1700. 1991
  • Electrophysiologic analysis of early Parkinson’s disease.  41:44-48. 1991
  • Gaze–dependent hemianopia without hemispatial neglect.  41:1244-1250. 1991
  • HLA-A2, or a closely linked gene, confers susceptibility to early-onset sporadic alzheimer’s disease in mene.  41:1544-1548. 1991
  • Ipsilateral neglect in a patient following a unilateral frontal lesion.  41:2001-2004. 1991
  • Morphometric analysis of the prefrontal cortex in huntington’s disease.  41:1117-1123. 1991
  • Sagittal sinus thrombosis and leptomeningeal medulloblastoma.  41:455-456. 1991
  • United parkinson foundation neurotransplantation registry on adrenal medullary transplants: Presurgical, and 1– and 2–year follow–up.  41:1719-1722. 1991
  • Progressive aphasia: A precursor of global dementia? 1990
  • Bodily neglect and orientational biases in unilateral neglect syndrome and normal subjects.  40:640-643. 1990
  • Extrapyramidal involvement in Rett’s syndrome.  40:293-295. 1990
  • Multiple sclerosis sibling pairs: Clustered onset and familial predisposition.  40:1546-1552. 1990
  • Phenotypic heterogeneity of spinal muscular atrophy mapping to chromosome 5q11.2-13.3 (SMA 5q).  40:1831-1836. 1990
  • The intracarotid amobarbital procedure as a predictor of memory failure following unilateral temporal lobectomy.  40:605-610. 1990
  • Transmission and age-at-onset patterns in familial alzheimer’s disease: Evidence for heterogeneity.  40:395-403. 1990
  • Changes in survival after transient ischemic attacks: Observations comparing the 1970s and 1980s.  39:982-985. 1989
  • Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumor.  39:62-66. 1989
  • Hemispatial visual inattention masquerading as hemianopia.  39:1125-1127. 1989
  • Ocular stroke and carotid artery dissection.  39:1462-1464. 1989
  • Phenotypic variation in 2 huntington’s disease families with linkage to chromosome 4.  39:1332-1336. 1989
  • Reply from the authors: Hemispatial neglect.  39:458. 1989
  • Reply from the authors: Hemispatial neglect.  39:1006. 1989
  • Seizures after primary intracerebral hemorrhage.  39:1089-1093. 1989
  • Altitudinal neglect.  38:277-281. 1988
  • Attention deficit disorder in children: A neglect syndrome?.  38:806-808. 1988
  • Clinical and neuropathologic assessment of severity in huntington’s disease.  38:341-347. 1988
  • Dopaminergic effects on simple and choice reaction time performance in Parkinson’s disease.  38:249-254. 1988
  • Hemispatial neglect affected by non-neglected stimuli.  38:1207-1211. 1988
  • Motor dominance and lateral asymmetry of the globus pallidus.  38:388-390. 1988
  • Right cerebral specialization for tactile attention as evidenced by intracarotid sodium amytal.  38:1763-1766. 1988
  • Cognitive evoked potentials and disorders of recent memory.  37:526-529. 1987
  • Dopamine agonist therapy for neglect in humans.  37:1765-1770. 1987
  • Perseveration in behavioral neurology 1987
  • Reduction in cerebral activation after right hemisphere stroke.  37:957-962. 1987
  • Remote memory and neglect syndrome.  37:522-526. 1987
  • Aneurysmal compression of the anterior visual pathways.  36:1035-1041. 1986
  • Krabbe disease: Specific MRI and CT findings.  36:111-115. 1986
  • Multimodal agnosia after unilateral left hemisphere lesion.  36:864-867. 1986
  • Normal tactile threshold in monkeys with neglect.  36:636-640. 1986
  • A comment on the “comprehension of affective and nonaffective prosody”.  35:1085. 1985
  • Acquired stuttering from a right hemisphere lesion in a right-hander.  35:1343-1346. 1985
  • Directional hypokinesia: Prolonged reaction times for leftward movements in patients with right hemisphere lesions and neglect.  35:855-859. 1985
  • Comprehension of affective and nonaffective prosody.  34:917-921. 1984
  • Pure word deafness after bilateral primary auditory cortex infarcts.  34:347-352. 1984
  • Reading: Selective sparing of closed-class words in Wernicke’s aphasia.  34:1038-1045. 1984
  • The effect of corpus callosum lesions on unilateral neglect in monkeys.  34:812-815. 1984
  • Performance on hemispatial pointing task by patients with neglect syndrome.  33:661-664. 1983
  • Phonological agraphia: Writing by the lexical-semantic route.  33:755-765. 1983
  • Preserved oral reading in Wernicke’s aphasia.  33:916-920. 1983
  • Affect in subcortical aphasia.  32:102-103. 1982
  • Nonsensory neglect from parietotemporal lesions in monkeys.  32:1198-1201. 1982
  • Two forms of ideomotor apraxia.  32:342-446. 1982
  • Dorsal midbrain syndrome in multiple sclerosis.  31:196-198. 1981
  • Speech arrest in partial seizures: Evidence of an associated language disorder.  31:1016-1018. 1981
  • Unilateral hypokinesia and motor extinction.  31:445-448. 1981
  • Apomorphine-induced turning after recovery from neglect induced by cortical lesions.  30. 1980
  • Right hemisphere dominance for attention: The mechanism underlying hemispheric asymmetries of inattention (neglect).  30:327-330. 1980
  • Thalamic neglect.  29:690-694. 1979
  • Hypoarousal in patients with the neglect syndrome and emotional indifference.  28:229-232. 1978
  • Transient ischemic attacks: A prospective study of 225 patients.  28:746-753. 1978
  • Discrimination and evocation of affectively intoned speech in patients with right parietal disease.  27:947-950. 1977
  • Korsakoff’s syndrome resulting from bilateral fornix lesions.  27:490-493. 1977
  • Metrizamide encephalography: The use of a new, CSF soluble contrast agent.  27:388. 1977
  • Defective motor learning in ideomotor apraxia.  25:1018-1020. 1975
  • Stroke in a 15-year-old girl secondary to terminal carotid dissection.  25:725-729. 1975
  • A case of a transient global amnesia due to a pitutary tumor.  24:998-1000. 1974
  • Neglect after mesencephalic reticular formation lesions.  24:294-298. 1974
  • Subarachnoid hemorrhage caused by rupture of a small superficial artery.  24:319-321. 1974
  • An audiometric defect in temporal lobe dysfunction.  23:384-386. 1973
  • Neglect after cingulectomy.  23:1003-1007. 1973
  • Frontal lobe neglect in man.  22:660-664. 1972
  • Neoplasms of the central nervous system: Epidemiologic considerations.  22:40-48. 1972
  • Haloperidol treatment of chorea associated with systemic ludusi ervthematosus.  21:963-965. 1971
  • Neoplasms of the central nervous system: epidemiologic considerations..  20:398-399. 1970
  • Steroid suppression of meningeal inflammation caused by pantopaque.  9:48-52. 1959
  • Neonatal seizures in premature infants with IVH: are myoclonic jerks seizures?.  88:92-95.
  • International Standard Serial Number (issn)

  • 0028-3878
  • 1526-632X
  • Electronic International Standard Serial Number (eissn)

  • 0028-3878
  • 1526-632X